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Background: Toll-like receptor (TLR) activation is hypothesized to contribute to inflammatory eye disease including
uveitis, yet the distribution pattern of TLRs in human uveal tissues remains poorly described. The purpose of this
study was to investigate the expression profile of TLRs in human iris pigment epithelial cells (IPE) at the gene and
protein level and examine the effect of pathogen-associated molecular patterns (PAMPs), such as Pam3CSK4.3HCl,
Poly(I:C), lipopolysaccharides (LPS from E. coli serotype O111:B4), Flagellin, MALP-2 (macrophage activating
lipopeptide-2), Poly(U) and CpGODN2395 on the production of inflammatory mediators including interleukin-8 (IL-8)
and monocyte chemotactic protein 1 (MCP-1) from human IPE and retinal pigment epithelial cells (RPE).
Methods: RT-PCR and Western blotting was employed to investigate the expression of TLRs 1–10 in primary IPE
and RPE. Secretion of IL-8 or MCP-1 following treatment with PAMPs was measured by ELISA. The role of TLR2,
TLR3 and TLR4 in mediating an inflammatory response was investigated using pharmacological TLR inhibitors.
Results: IPE and RPE expressed transcripts for TLR1-6 and 8–10; and proteins for TLR1-6 and 9. IPE secreted IL-8 or
MCP-1 in response to Pam3CSK4.3HCl, Poly(I:C), LPS and MALP-2, whereas RPE produced IL-8 only after Poly(I:C), LPS
or MALP-2 treatment. TLR inhibitors (OxPAPC, CI-095 and chloroquine) blocked IL-8 secretion in Poly(I:C), LPS or
MALP-2-treated IPE and RPE.
Conclusions: Ocular pigment epithelial cells respond to PAMPs through activation of TLRs, particularly TLR2, TLR3
and TLR4. Expression of TLRs in human IPE cells provides a basis for responses to many ocular pathogens and their
activation may be involved in the pathogenesis of ocular inflammation.
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Toll-like receptors (TLRs) are a family of phylogenetically
conserved transmembrane pattern recognition receptors
involved in innate immunity and inflammation. To date,
10 functional TLRs have been reported in humans [1]
which recognise unique and highly conserved molecular
signatures from microbes known as pathogen associated
molecular patterns (PAMPs) that include lipopolysaccha-
rides (LPS), flagellin, lipopeptides, lipotechoic acid (LTA),
microbial DNA, viral RNAs and others [1].* Correspondence: d.wakefield@unsw.edu.au
1Inflammation and Infection Research Centre, Department of Pathology,
School of Medical Sciences, Faculty of Medicine, University of New South
Wales, Sydney, Australia
4UNSW Medicine, University of New South Wales, Sydney, Australia
Full list of author information is available at the end of the article
© 2014 Mai et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.TLRs have been implicated in ocular inflammation.
For example, activation of TLRs by PAMPs due to an
initiating mucosal infection and the subsequent immune
response has been hypothesised to play a key role in the
pathogenesis of anterior uveitis [2]. In addition, expres-
sion of TLR2 in human conjunctival epithelial cells was
shown to play a significant role in the chronic ocular in-
flammatory response to Staphylococcus aureus [3]. Kezic
et al. [4] suggested that both epithelial cells and immune
cells play a role in ocular inflammation. Specifically,
radiation-resistant, non-bone marrow derived ocular cells,
such as iris endothelial cells or nonpigmented ciliary body
epithelial cells, play a greater role in the development of
endotoxin-induced uveitis (EIU) than bone marrow-
derived macrophages and dendritic cells residing in the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.journal-inflammation.com/content/11/1/20eye [4]. Therefore, studying TLRs on iris pigment epithe-
lial cells (IPE) and their response to PAMPs may provide
an insight into pathogenesis of ocular inflammation,
particularly anterior uveitis.
The iris pigment epithelium is the layer of pigmented
cells forming the posterior layer of the iris [5]. There is a
remarkable resemblance between IPE and retinal pigment
epithelial cells (RPE) due to their shared embryonic devel-
opment [6-8]. In vitro, IPE and RPE share functional prop-
erties such as phagocytosis and synthesis of cytokines and
growth factors [7,9]. Rezai and colleagues showed that
IPE elicited phagocytic activity similar to RPE [7]. Non-
immune cells, such as IPE and RPE, form an interface
between the eye and the environment that is not readily
accessible to myeloid cells. By virtue of their ability to
detect signals via innate immune receptors, such as toll-
like receptors, they are able to recruit myeloid cells,
such as neutrophils and macrophages to the site of
injury and induce inflammation.
Expression of TLRs has been reported in a number of
ocular tissues such as cornea, conjunctiva, sclera and
retina [10-14]. Studies have emphasized the importance
of the LPS receptor complex (TLR4 and co-receptors
CD14 and MD2) expression in ocular tissues and cells
such as corneal epithelial cells, cornea stroma fibroblasts,
human ciliary body, human iris endothelial cells (TLR4
only), RPE and resident antigen presenting cells in human
uvea [14-18]. It has been shown that human RPE express
TLRs and are considered to play an important role in pos-
terior ocular inflammation due to their ability to secrete
several inflammatory mediators [13,19]. However, little is
known about the distribution of TLRs in the uvea, espe-
cially the iris. In this study, we investigated the expression
pattern and functional significance of TLRs in human
ocular pigment epithelial cells (IPE and RPE). This study
demonstrated that human IPE and RPE secrete IL-8 and
MCP-1 in response to PAMPs, which was partially medi-
ated through TLR activation.
Methods
Primary ocular pigment epithelial cells
Donor human eyes were obtained from Lions NSW
Eye Bank, Sydney, Australia within 16 hours of death.
Collection of all human samples followed the Tenants
of the Declarations of Helsinki and had institutional
Human Research Ethics Committee approval (HERC11190;
HERC10026). Donor matched IPE and RPE were isolated
from human eyes (n = 3 donors) using a previously de-
scribed method [20] with minor modifications. Briefly,
globes were bisected into anterior and posterior segments
and the retina was peeled away to expose the RPE. The iris
was removed and placed into a culture dish. Ocular tissues
were incubated in 0.25% Trypsin/EDTA at 37°C for
3 hours and IPE and RPE were mechanically removed.Isolated cells were washed in phosphate buffered saline
(PBS) and collected by centrifugation. Cell suspensions
were transferred to T-25 culture flasks containing epi-
thelial cell medium (ScienCell Research Laboratories,
San Diego, CA) supplemented with 2% FBS, 100 U/ml
penicillin and 100 μg/ml streptomycin and maintained
at 37°C in an atmosphere of 5% CO2. Primary IPE
(≤passage 4) and RPE (≤passage 5) were used in all exper-
iments. Cells were probed with an anti-human pan-
cytokeratin antibody (Clone C-11, Sigma-Aldrich, St
Louis, MO) to ensure they were of epithelial origin before
experimentation (see Additional file 1). The spontaneously
arising retinal pigment epithelial cell line (ARPE-19), pre-
viously characterised by Dunn et al. [21], were cultured in
a 1:1 mixture of DMEM and Ham’s F12 medium supple-
mented with 2% FBS, 100 U/ml penicillin and 100 μg/ml
streptomycin. Human acute monocytic leukemia cells
(THP-1) were cultured in RPMI 1640 medium supple-
mented with 10% FBS, 100 U/ml penicillin and 100 μg/ml
streptomycin as described previously [22] and both were
used as positive controls.
Antibodies and TLR ligands
Anti-TLR, −GAPDH and isotype control antibodies were
purchased from eBioscience (San Diego, CA), Imgenex
(San Diego, CA) and R&D systems (Minneapolis, MN;
see Table 1 for details). Secondary antibodies biotinyl-
ated anti-goat, mouse or rabbit immunoglobulins and
HRP-conjugated streptavidin were purchased from DAKO
(Glostrup, Denmark). TLR ligands used for functional as-
says were either endotoxin-free or endotoxin-minimized
(see Table 2 for details).
Real-time and reverse transcription polymerase chain
reaction (RT-PCR)
Total RNA was isolated from IPE and RPE using TRI re-
agent® (Sigma-Aldrich, USA) according to manufacturer’s
instruction. Total RNA (1 μg) was reverse transcribed into
cDNA using SuperScript™ III RT system (Invitrogen,
Grand Island, NY) with oligo dT primers. Each PCR re-
action mixture contained 1 μl of cDNA template, 2 μl of
TLRs primer mix (Table 3), 10 μl of LightCycler® 480
Sybr green I master (Roche Diagnostics, IN, USA) and
RNase-free water in a total volume of 20 μl. The assay
was performed in a LightCycler® 480 Real-Time PCR in-
strument (Roche) with an initial activation at 95°C for
10 minutes, followed by amplification of 45 cycles with
2 steps (denaturation at 95°C for 10 seconds, combined
annealing and extension at 60°C for 30 seconds). The
experiment was performed in duplicate and included
negative controls which contained no cDNA template.
The concentration of TLR genes was determined using
the comparative threshold cycle (CT) number and nor-
malized to that of GAPDH.
Table 1 Antibodies used for Western blotting
Antigen specificity Antibody subtype Label Clone Manufacturer Final concentration
(μg/ml) or dilution
TLR1 Goat IgG biotin - R&D systems 0.2
TLR2 Goat IgG biotin - R&D systems 0.2
TLR3 Mouse IgG1, k - 40C1285.6 Imgenex 2
TLR4 Goat IgG biotin - R&D systems 0.2
TLR5 Mouse IgG2a, k - 19D759.2 Imgenex 2
TLR6 Rabbit IgG - - Imgenex 2
TLR7 Rabbit IgG - - Imgenex 2
TLR8 Mouse IgG1, k - 44C143 Imgenex 2
TLR9 Mouse IgG1, k - 26C593.2 Imgenex 2
TLR10 Mouse IgG1 - 158C1114 Imgenex 2
Isotype Mouse IgG2a, k - - eBioscience 10
GAPDH Mouse IgG1 - GAPDH 1D4 Imgenex 1:1000 dilution
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contained 1 μl of cDNA, 200 nM each of TLR forward
and reverse primer (Table 3), 200 μM dNTPs, 2.5 mM
MgCl, 1 U Platinum Taq DNA polymerase (Invitrogen)
and made up to 20 μl with DEPC-treated water. PCR
was performed using a GeneAmp® PCR system 9700
(Applied Biosystems, Foster City, CA) with the following
conditions: initial denaturation at 95°C for 2 minutes,
followed by 35 cycles with 3 steps (denaturation at 95°C
for 30 seconds, annealing at 60-62°C, depending on GC
and AT contents of primers, for 30 seconds, and extension
at 72°C for 30 seconds) and a final extension at 72°C for
2 minutes. PCR products were displayed on 2% agarose
gels after electrophoresis. Images were taken using a
Molecular Imager® Gel Doc™ system (Bio-Rad, Hercules,
CA) after staining with GelRed Nucleic acid stain (Bio-
tium Inc, Hayward, CA). TLR transcripts were quantified
by densitometry and normalised against GAPDH which




Pam3CSK4.3HCl Synthetic tripalmitoylated lipopeptide, an analog of the imm
N-terminal portion of bacterial lipoprotein
Poly(I:C) Synthetic mimetic of viral double-stranded RNA
Flagellin Isolated from Salmonella typhimurium strain 14028; highly co
among gram negative and gram positive bacteria, especially
and 100 C-terminal amino acid
MALP-2 Synthetic macrophage-activating lipopetides-2 isolated from
fermentans
Poly(U) Synthetic analog of single-stranded RNA
CpG ODN2395 Synthetic oligodeoxynucleotides containing unmethylated d
deoxyguanosine (CpG) motif, mimicking the effects of bacte
LPS (O111:B4) Extracted from Escherichia coli serotype O111:B4 and purifiedWestern blotting
Whole cell lysates from IPE and RPE were prepared as
previously described [23]. Briefly, cells were incubated
for 30 minutes in ice cold lysis buffer (0.1% SDS, 0.5%
NP-40 in 50 mM Tris–HCl pH 7.4) supplemented with
a protease inhibitor cocktail (Complete Protease Inhibi-
tor Cocktail, Roche, Mannheim, Germany). Lysates were
centrifuged at 10,000 g for 10 minutes at 4°C and protein
concentration measured using the DC Protein Assay (Bio-
Rad, Hercules, CA). Proteins from lysates (20 μg) were
separated by 10% SDS-PAGE under non-reduced con-
ditions, transferred to PVDF membranes, then blocked
in 5% skim milk/Tris buffered saline (TBS) at 4°C for
16 hours. Membranes were subsequently incubated with
appropriate primary antibodies (Table 1) in 1% BSA/TBS
for 1 hour at room temperature, followed by one hour in-
cubation in biotinlyated anti-goat, -mouse or -rabbit IgG
(1:2000 dilution; Dako) and HRP-conjugated streptavidin





unologically active < 0.01 EU/μg TLR1/2 TLR Ligands Set I
(Apotech®, Switzerland)
< 0.01 EU/μg TLR3
nserved molecules
in 170 N-terminal
< 0.1 EU/μg TLR5
Mycoplasma < 0.01 EU/μg TLR2/6
< 0.1 EU/μg TLR7/8
eoxycytosine-
rial DNA
< 0.1 EU/μg TLR9
by ion exchange - TLR4 Sigma-Aldrich, St.
Louis, MO
Table 3 TLR specific primers and RT-PCR conditions
Genes Sequence (5′ to 3′ direction) Annealing temperature (°C) Cycles Amplicon size (bp)
TLR1 F: AAAAGAAGACCCTGAGGGCC 62 35 340
R: TCTGAAGTCCAGCTGACCCT
TLR2 F: GTACCTGTGGGGCTCATTGT 62 35 191
R: CTGCCCTTGCAGATACCATT
TLR3 F: AAATTGGGCAAGAACTCACAGG 60 35 320
R: GTGTTTCCAGAGCCGTGCTAA
TLR4 F: TACAAAATCCCCGACAACCTC 60 35 264
R: AGCCACCAGCTTCTGTAAACT
TLR5 F: TGCATTAAGGGGACTAAGCCTC 60 35 351
R: AAAAGGGAGAACTTTAGGGACT
TLR6 F: TCTTGGGATTGAGTGCTATGA 60 35 337
R: GTCGTTTCTATGTGGTTGAGG
TLR7 F: TCCAGTGTCTAAAGAACCTGG 60 38 352
R: TGGTAAATATACCACACATCCC
TLR8 F: TAATAGGCTGAAGCACATCCC 60 35 621
R: TCCCAGTAAAACAAATGGTGAG
TLR9 F: GTGCCCCACTTCTCCATG 60 35 260
R: GGCACAGTCATGATGTTGTTG
TLR10 F: TGACCACAATTCATTTGACTACTC 60 35 478
R:TTGAATACTTTTGGGCAAGCACC
GAPDH F:ACCACAGTCCATGCCATCAC 60 28 452
R:TCCACCACCCTGTTGCTGTA
Genes Sequence Accession number Cycles Amplicon size (bp)
TLR2* Sequences refer to Qiagen NNM_003264 45 92
TLR3* NNM_003265 45 90
TLR4* NNM_138554 45 111
TLR6* NNM_006068 45 78
GAPDH* NNM_001256799 45 95
F = forward primer; R = reverse primer; bp = base pair. *Primer mix used for real-time PCR.
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cence Substrate (PerkinElmer Inc, Waltham, MA).
In vitro cell culture studies
Primary IPE and RPE were seeded at a density of 3 ×
103 cells/ml in 24-well plates (NUNC, Denmark) and
used for experimentation once they reached confluence.
Briefly, cells were washed extensively in sterile PBS to
remove residual serum, followed by serum starvation for
16 hours. On the following day, cells were stimulated
with various concentrations of TLR ligands (Table 2)
under serum free conditions at 37°C for 24 hours. Con-
ditioned media was collected and centrifuged at 10,000 g
for 10 minutes to eliminate cell debris. IL-8 and MCP-1
content was measured using Human CXCL8/IL-8 and
CCL2/MCP-1 DuoSet ELISA Development kit (R&D
systems, Minneapolis, MN), respectively.For TLR inhibition studies, cells were cultured to conflu-
ence in 24-well plates and serum starved as described above.
On the following day, they were incubated with various
concentrations of OxPAPC (TLR2 and TLR4 inhibitor,
InvivoGen, San Diego, CA) [24] for 30 minutes, or CI-095
(TLR4 inhibitor, InvivoGen, San Diego, CA) [25,26] for 60mi-
nutes at 37°C, or chloroquine (TLR3 inhibitor, InvivoGen,
San Diego, CA) [27] for 60 minutes, then stimulated
with LPS from E. coli serotype O111:B4 (Sigma-Aldrich, St.
Louis, MO), MALP-2 (Apotech®, Switzerland) or Poly(I:C)
(Apotech®, Switzerland) for 24 hours. Conditioned media
was collected and the IL-8 or MCP-1 levels measured by
ELISA as described above. Trypan blue exclusion was used
to assess cell viability in the presence of high concentrations
of the inhibitors (0.1 - 10 μg/ml for both OxPAPC and CI-
095; 10–50 μM for chloroquine) in order to monitor the
toxicity of the inhibitors to the cells.
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Experiments were performed in triplicate and values were
presented as mean ± standard deviation. One-way ANOVA
followed by Dunnett’s post test or Bonferroni’s multiple
comparison test were used to compare responses between
controls and treatment groups; a p value of <0.05 was
considered significant. All data analysis was performed
using GraphPad Prism (version 5, GraphPad Software).
Results
Human IPE and RPE express TLRs
Real time-PCR analysis revealed that human IPE and RPE
expressed mRNA for TLR2, −3, −4 and −6 (Figure 1A)
which were also expressed in positive controls ARPE-19
and THP-1 cell lines (Figure 1B and C). Negative control
reactions containing no cDNA template or no RT enzyme
generated no amplicons (Data not shown). Interestingly,
expression of TLR4 mRNA was higher than that of the
other genes (TLR2, −3 and −6) in IPE, RPE and ARPE-19Figure 1 Expression of TLR2, −3, −4 and −6 mRNA and proteins in hu
cultured to confluence and expression of TLR2, −3, −4 and −6 mRNA and
blotting (D, E and F) using specific primers and antibodies, respectively. The c
cycle number and normalised to that of the GAPDH with ARPE-19 (B) and TH
Two-way ANOVA and Bonferroni’s multiple comparison test was used to anal
Turkey’s multiple comparison test was used to analyse the data for B and
representative of three independent experiments (the results are consistewhereas both TLR2 and −4 genes were highly expressed in
THP-1. For example, IPE expressed higher TLR4 than
TLR2 genes by 20.8 fold, (Table 4) and a similar pattern
was observed in RPE and ARPE-19. Western blotting was
performed to further confirm the expression of TLR pro-
teins in human IPE and RPE. Specific bands representing
TLR2, −3, −4 and −6 proteins were detected from IPE and
RPE (Figure 1D and F) as well as in ARPE-19 and THP-1
cell lines (Figure 1E) and the results were consistent. An
additional data presented in Appendix (see Additional
file 2) showed gene and protein expression of other TLRs.
IPE and RPE secrete IL-8 and MCP-1 in response to PAMPs
IPE secreted significantly increased levels of IL-8 in
response to Poly(I:C), LPS and MALP-2 (macrophage-
activating lipopeptide-2) (Figure 2A). A similar profile
was observed when IPE was stimulated with higher (2x)
dose of the same ligands as well as Pam3CSK4.3HCl
(Figure 2B). Increasing concentration of Poly(I:C) beyondman IPE and RPE. Human IPE and RPE (A) from the same donor were
proteins was investigated by real-time PCR (A, B and C) and Western
oncentration of genes was measured using the comparative threshold
P-1 (C) served as positive controls. Data represents mean ± SD (N = 3).
yse the data for A, **p < 0.01, ****p < 0.0001. One-way ANOVA and
C, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Results are
nt from three donors).
Table 4 Fold changes in TLR2, −3, −4 and −6 mRNA
expression in IPE, RPE, ARPE-19 and THP-1 cells
IPE RPE ARPE-19 THP-1
Genes Fold changes
TLR2 1 1 1 1
TLR3 4.21 2.95 6.86 0.12
TLR4 20.82 16.64 15.3 0.92
TLR6 1.22 1.14 2.31 0.25
Results were normalised to GAPDH and presented as fold changes compared
to TLR2 gene.
For example, ARPE-19 cells expressed higher TLR3 than TLR2 genes by
6.86 folds.
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that a maximal IL-8 secretion was observed at a dose of
50 μg/ml. However, flagellin, poly(U) and CpG ODN2395
(synthetic oligodeoxynucleotides) did not enhance IL-8 se-
cretion (Figure 2A, B). TLR7 and 8 were not expressed by
IPE or RPE (see Additional file 2) which may explain why
they do not respond to Poly(U) stimulation. Whereas RPE
secreted IL-8 in response to Poly(I:C) and MALP-2 but
did not respond to Pam3CSK4.3HCl, LPS (O111:B4), fla-
gellin, poly(U) or CpG ODN2395 (Figure 2D). A similar
response profile, except LPS stimulation, was observed
when RPE were stimulated with higher (2x) doses of the
same ligands (Figure 2E). A similar trend was seen when
MCP-1 was assayed. Both IPE and RPE secreted MCP-1
in response to the same ligand stimulation (Figure 2C, F),
which is consistent with the IL-8 production profile. Inter-
estingly, IPE were more sensitive than RPE in their re-
sponse to PAMPs as more IL-8 and MCP-1 was produced
by IPE than RPE at the same dose of ligand stimulation.
LPS and Poly(I:C) dose–response experiments were per-
formed and maximal IL-8 secretion was observed at a final
concentration of 10 μg/ml for both cell types (Figure 3
panel 1, A, C) and 50 μg/ml for IPE (Figure 3 panel 1, B),
respectively. However, maximal IL-8 secretion was not
seen from RPE (Figure 3 panel 1, D) at the concentra-
tions tested here. Higher dose of Poly(I:C) stimulation
(>100 μg/ml) is required to investigate maximal IL-8
secretion for RPE. Time course experiments were per-
formed at 24, 48, 72 and 96 hours. Secretion of IL-8
from IPE and RPE in response to LPS (O111:B4) was
observed at 24, 48 and 72 hours (Figure 3 panel 2, A, B). It
was noted that accumulated effect of IL-8 occurred at later
time points (72 and 96 hours; i.e. IL-8 level was increased
due to cultured medium was vaporized beyond 72 hours)
therefore subsequent experiments were performed at
24 hours.
TLR inhibitors block IL-8 secretion in IPE and RPE
stimulated cells
OxPAPC (TLR2 and 4 inhibitor), CI-095 (TLR4 inhibitor),
chloroquine (TLR3 inhibitor) significantly inhibited IL-8secretion in both IPE and RPE challenged with LPS
(Figure 4A, B, E and F), MALP-2 (Figure 4C and G) or
Poly(I:C) (Figure 4D and H), confirming their specificity
to TLR2, −3 and −4 respectively. Negative controls con-
taining various concentrations of inhibitors were also in-
cluded to monitor the level of IL-8 secretion with no
ligand stimulation (Figure 4). The negative controls con-
tained minimal level of IL-8, similar to the samples con-
taining basal medium alone. In addition, ~90% of IPE and
RPE remained viable in the presence of 0.1 - 10 μg/ml for
both OxPAPC and CI-095; 10–50 μM for chloroquine
(see Additional file 3), suggesting that cell death did not
account for reduction in IL-8 secretion (i.e. the inhibitors
were not toxic to the cells). Therefore, IPE and RPE
secreted IL-8 in response to LPS and MALP-2 stimulation
is likely mediated through TLR4 and TLR2/6, respectively,
whereas Poly(I:C) is through TLR3 signalling.
Discussion
This is the first report to characterise the expression
profile of TLRs in human IPE. IPE and RPE expressed
TLR1-6 and 8–10 transcripts; TLR1-6 and 9 proteins
(see Additional file 2) however TLR7, 8 and 10 proteins
were not detected. Real-time PCR was performed to fur-
ther confirm whether there is differential expression of
TLR2, −3, −4 and −6 genes in both cell types (Figure 1).
Additionally, IPE and RPE expressed higher TLR4 levels
than TLR2 and this may account for its higher responsive-
ness to LPS than Pam3CSK4.3HCl stimulations (Figures 1
and 2). IPE may have been more responsive to LPS stimu-
lation than RPE due to the fact that they expressed higher
TLR4 levels than RPE (Figures 1 and 2). The level of TLR3
mRNA and proteins was not significantly different be-
tween the two cell types under basal medium (Figure 1 A).
However, IPE and RPE showed different sensitivity in
response to Poly(I:C) stimulation. In addition, both
cells showed higher expression of TLR4 mRNA and
proteins than that of TLR3. They secreted higher level
of IL-8 in response to Poly(I:C), compared to LPS
stimulation (Figure 2). It is noteworthy that the experi-
ments conducted for Figure 1 were performed with
basal medium. Hence, further study is needed to inves-
tigate the level of TLR2, −3, −4, −6 mRNA and proteins
following ligand stimulation. Nevertheless the presence
of TLR proteins detected by Western blotting may not
necessarily reflect on the amount of the proteins in-
volved in the signalling. Some of the proteins may be
degraded or undergo post-translational modification
for functioning. Interestingly, TLR7 mRNA was not
detected in either cell type and this may well explain
the absence of TLR7 proteins. The lack of TLR8 and 10
proteins in ocular pigment epithelial cells may reflect
the low expression levels, which in turn may influence
their response to PAMPs.
Figure 2 Human IPE and RPE exhibit different sensitivities in response to PAMPs. IPE (A, B and C) and RPE (D, E and F) from the same
donor were stimulated with PAMPs such as Pam3CSK4.3HCl, Poly(I:C), LPS (serotype O111:B4), Flagellin, MALP-2 (macrophage activating lipopeptide-2),
Poly(U) and CpGODN2395 at a lower (A and D) and higher dose (B, C, E and F), under serum free condition for 24 hours (control = basal
media). Conditioned media were collected and assayed for IL-8 or MCP-1 by ELISA. Data represents mean ± SD (N = 3). One-way ANOVA and
Dunnett’s posttest was used to compare ligand-treated samples to controls, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Results are
representative of three experiments (the results are consistent from three donors).
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findings that these cells express a functional LPS receptor
complex (TLR4, MD-2, and CD14) in vitro and secreted
several pro-inflammatory cytokines including IL-6, IL-8,
MCP-1, IP-10, MIP-1-beta and RANTES in response to
LPS stimulation [23]. Here, we showed that RPE expressed
all TLR transcripts except TLR7. In contrast, Kumar and
colleagues reported that human RPE express all TLR
mRNAs except TLR8 [13]. This difference may be due to
donor variation, different culture conditions or different
time in culture (passage 2–5 in our study versus passage7–12). In our studies, both IPE and RPE became less re-
sponsive to TLR ligands with increasing passage and failed
to respond beyond generation 5 and 6 respectively (results
not shown). Our results seem more reliable as low passage
number cultures and donor-matched primary IPE and
RPE were used, and the medium was formulated to pro-
mote optimal epithelial growth.
Previous studies used a well-characterised cell line,
ARPE-19 (spontaneous arising retinal pigment epithelial
cells), as representative of retinal pigment epithelial cells
(RPE). In our previous study, we showed that there is a
Figure 3 Dose response and time course of IL-8 secretion from LPS or Poly(I:C) treated IPE and RPE. Panel 1: Dose response; IPE (A and B)
and RPE (C and D) from the same donor were stimulated with various concentrations of LPS (serotype O111:B4) or Poly(I:C) under serum free
condition for 24 hours (control = basal media). Panel 2: Time course; LPS stimulation was performed at a maximal dose of 10 μg/ml under
serum free condition for 24, 48 and 72 hours (□ = media only; ■ = LPS stimulation). Conditioned media were collected and assayed for IL-8 by
ELISA. Data represents mean ± SD (N = 3). One-way ANOVA and Dunnett’s post test was used to compare LPS or Poly(I:C) treated samples to
controls from panel 1, **p < 0.01, ***p < 0.001, ****p < 0.0001. Two-way ANOVA and Bonferroni’s multiple comparison test were used to analyse
the data from panel 2. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Results are representative of three experiments.
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Figure 4 (See legend on next page.)
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Figure 4 TLR inhibitors suppress IL-8 secretion from LPS, MALP-2 or Poly(I:C) treated IPE and RPE. IPE (A-D) and RPE (E-H) from the same
donor were stimulated with LPS (serotype O111:B4; 10 μg/ml - maximal dose), MALP-2 (100 ng/ml) or Poly(I:C) (10 μg/ml) in the presence of
OxPAPC (TLR2 and 4 inhibitors), CI-095 (TLR4 inhibitor) and chloroquine (TLR3 inhibitor) respectively, at various concentrations (□ =media only;
■ = LPS stimulation). Conditioned media were collected and assayed for IL-8 by ELISA. Data represents mean ± SD (N = 3). One-way ANOVA and
Bonferroni’s multiple comparison test were used to analyse the data. IL-8 secretion by LPS, MALP-2 or Poly(I:C) treated IPE and RPE was significantly
inhibited in the presence of OxPAPC, CI-095 or chloroquine in comparison to exposed to the ligand alone, *p < 0.05, **p < 0.01, ***p < 0.001. Results
are representative of three experiments (two studies from the same donor and the results are consistent from three donors).
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between IPE and ARPE-19 [23]. However, expression of
CD14 from donor-matched primary IPE and RPE was
not significantly different between the two cell types
(data not shown). In addition, it has been shown that an
elevated expression of proteins associated with micro-
tubule cytoskeleton and IL-18 production was observed
in ARPE-19 in comparison to RPE [28,29]. Therefore,
the results generated from ARPE-19 should be inter-
preted with caution, as they may not be a reliable substi-
tute for the primary cultured cells.
Although IPE and RPE possess a similar TLR expres-
sion profile, IPE appears to be more sensitive to PAMPs
than RPE in culture and this observation was consistent
across all three IPE and RPE matched donors (Figure 2).
Culture supernatants confirmed that both IPE and RPE
secreted a similar amount of total protein. IPE secreted
maximal levels of IL-8 at 50 μg/ml following Poly(I:C)
stimulation, whereas RPE required significantly higher
dose of poly(I:C) (>100 μg/ml) for maximal IL-8 secre-
tion. It was noted that high dose of LPS stimulation
(10 μg/ml) was needed for a significant response in RPE.
A recent finding suggests that LPS can be recognised in
a TLR4-independent, caspase 11-dependent manner in
mice and this activation was serotype specific, occurring
in response only to E. coli serotype O111:B4 [30]. In our
study the same serotype of LPS from E. coli was used.
Therefore it cannot be ruled out the possibility that
LPS mediated IL-8 secretion in RPE may be TLR4-
independent.
The pro-inflammatory cytokines, IL-8, was chosen for
this study based on our previous findings: (i) that IL-8,
MCP-1, IP-10, RANTES and MIP-1b were significantly
increased in aqueous humour of patients with active
stage of anterior uveitis and this correlated with the clin-
ical severity of the disease [31]; (ii) IL-8 has been shown to
contribute to the chemotactic signal for the recruitment of
leukocytes in EIU [32]. Therefore, IL-8 is an important
mediator of the inflammatory response in clinical settings
and in experimental animal models of uveitis.
MCP-1 is one of the key chemokines that regulate mi-
gration and infiltration of monocytes\macrophages to the
sites of inflammation due to infection or tissue injury. The
fact that IPE and RPE secreted both IL-8 (neutrophil
chemoattractant) and MCP-1 in response to PAMPs areconsistent with their role in innate immune responses and
inflammation. IPE and RPE are regarded as “guardians”
of the eye as they sense danger signals and consequent
initiation of an inflammatory response. Whether the dif-
ferences in their responsiveness to PAMPs is due to the
nature of the cells; differential expression of TLRs and/
or their co-receptors or different down-stream TLR sig-
nalling pathways or mRNA and protein stability, remains
to be ascertained. Differential expression of TLRs and
their co-receptors in ocular pigment epithelial cells may
influence their response to PAMPs.
The role of TLR2, −3 and −4 in mediating cytokine re-
sponse in Poly(I:C), LPS or MALP-2-treated IPE and RPE
was also investigated using TLR inhibitors (OxPAPC,
CI-095 and chloroquine; Figure 4). OxPAPC is an in-
hibitor of TLR2 and -4 signaling by competing with
CD14, LBP and MD2, the accessory molecules that
interact with bacterial lipids [24]. Interestingly, IPE and
RPE showed different sensitivity to OxPAPC. For ex-
ample, IPE were more sensitive to OxPAPC in suppress-
ing LPS mediated IL-8 secretion than were RPE cells
(Figure 4A and E), but less sensitive to suppress MALP-2
mediated IL-8 secretion than RPE (Figure 4C and G). The
difference could be due to different levels of accessory
molecules of TLR4, such as CD14, LBP and MD2 on cell
surface between the two cell types. CI-095 (also known as
TAK-242) suppresses TLR4 signaling via its action on the
intracellular domain of TLR4 and inhibits the production
of nitric oxide and pro-inflammatory cytokines [25,26].
Chloroquine is a lysosomotropic agent that prevents endo-
somal acidification thus blocks signalling of intracellular
TLRs [27]. Both IPE and RPE showed similar response/
sensitivity to CI-095 and chloroquine, which are potent in-
hibitors for TLR4 and TLR3, respectively. The fact that
OxPAPC, CI-095 and chloroquine inhibited IL-8 secretion
from LPS, MALP-2 or Poly(I:C)-treated IPE and RPE, sug-
gests a role for TLR4 and possibly TLR2, TLR3 in LPS,
MALP-2, Poly(I:C) mediated inflammatory responses.
A limitation of our study is that we employed a cell
culture system. Nevertheless, animal studies support
the concept that TLRs play a role in the pathogenesis
of experimental autoimmune uveitis and EIU [4,33-35].
In addition, animal studies also provide an insight into
physiological relevance of pro-inflammatory cytokine pro-
duction in vivo. For example, Allensworth et al. showed
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concluded that all TLR agonists tested induced inflamma-
tion in the mouse eye with a marked increase of TNF-α,
IL-6, IP-10, MCP-1 and KC and relatively little production
of IFN-γ, IL-10, IL-12, IL-17, IL-1β, IL-4 or RANTES. In
the current study, we have shown for the first time that
cultured IPE cells express functional TLRs and respond to
PAMPs through activation of TLRs, particularly TLR2,
TLR3 and TLR4. This study extends the current know-
ledge of the role of TLR activation in iris culture and uveal
innate immune mechanism in the pathogenesis of ocular
inflammation.
Conclusion
Our results demonstrate that IPE cells express functional
TLRs and their activation may have implications for the
pathogenesis of ocular inflammation.
Additional files
Additional file 1: Human IPE and RPE stained for cytokeratin. The
primary IPE and RPE, cultured from iris and retina, of human donors, were
probed with anti-pan cytokeratin antibody (1:200 dilution; A) and an isotype
control antibody (mouse IgG1; 1: 200 dilution). Immunohistochemistry was
performed to confirm the epithelial origin of primary IPE and RPE. A
representative of cytokeratin stained IPE was shown in A and no
staining was seen in the negative control (IgG1). The result was
confirmed by flow cytometry (B). The peak representing cytokeratin
stained cells (in pink) was shifted away from that of the isotype control
antibody (in grey).
Additional file 2: Expression of TLR transcripts and proteins in
human IPE and RPE. Human IPE (lane 1) and RPE (lane 2) from the
same donor were cultured to confluence and expression of TLR1 to
TLR10 genes and proteins was investigated by reverse transcription PCR
(A) and Western blotting (B) using specific human TLR1 to TLR10 primers
and antibodies, respectively. M= 100 bp DNA ladder (100, 200, 300, 400,
500, up to 1000 bp from bottom to top). TLR mRNA expression was
measured by densitometry and normalised against GAPDH which served
as a loading control. Normalised TLR mRNA expression levels are
presented as mean ± SD (N=3) (C). Two-way ANOVA and Bonferroni’s
multiple comparison test were used to analyse the data, *p< 0.05,
**p< 0.01. Expression of TLR7 mRNA (A); TLR8 and TLR10 proteins (B)
were not detected in both IPE and RPE. Results are representative of
three experiments.
Additional file 3: Viability of IPE and RPE in the presence of
OxPAPC, CI-095 and chloroquine. IPE and RPE were cultured in various
concentrations of OxPAPC (A and D), CI-095 (B and E) and chloroquine
(C and F) for 24 hours. The cells were subsequently detached from
culture plates by trypsin, followed by assessment of viability using Trypan
blue. Data represents mean ± SD (N=3). One-way ANOVA and Dunnett’s
post test was used to compare inhibitor-treated samples to controls. Both
IPE and RPE remained ~90% viable in the presence of the high
concentrations of TLR inhibitors. There was no difference in cell viability
between control and inhibitor-treated cells.
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